ABBVIE INC
Acción · US00287Y1091 · ABBV · A1J84E (XNYS)
189,83 USD
06.06.2025 20:20
Cotizaciones actuales de ABBVIE INC
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria |
---|---|---|---|---|---|
![]() NYSE |
ABBV
|
USD
|
06.06.2025 20:20
|
189,83 USD
| 187,47 USD
+1,26 %
|
![]() XETRA |
4AB.DE
|
EUR
|
06.06.2025 15:35
|
167,20 EUR
| 164,80 EUR
+1,46 %
|
Rendimiento
Día | Semana | Mes | 3 meses | 6 meses | 1 año | 5 años |
---|---|---|---|---|---|---|
0,00 % | 2,00 % | 1,43 % | -9,93 % | 8,64 % | 12,01 % | 102,27 % |
Perfil de la empresa para ABBVIE INC Acción
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Fondos invertidos
Los siguientes fondos han invertido en: ABBVIE INC invertido:
Fondo | Vol. en millones 9.198,56 | Porcentaje (%) 2,52 % |
Fondo | Vol. en millones 2.322,89 | Porcentaje (%) 1,89 % |
Fondo | Vol. en millones 801,98 | Porcentaje (%) 1,68 % |
Fondo | Vol. en millones 3.006,31 | Porcentaje (%) 1,16 % |
Fondo | Vol. en millones 12.810,58 | Porcentaje (%) 1,06 % |
Datos de la empresa
Nombre ABBVIE INC
Empresa AbbVie Inc.
Símbolo ABBV
Sitio web
https://www.abbvie.com
Mercado principal
NYSE

WKN A1J84E
ISIN US00287Y1091
Tipo de valor Acción
Sector Healthcare
Industria Drug Manufacturers - General
CEO Mr. Robert A. Michael CPA
Capitalización de mercado 270 Mrd.
País Estados Unidos de América
Moneda USD
Empleados 55,0 T
Dirección 1 North Waukegan Road, 60064-6400 North Chicago
Fecha de OPV 2016-05-17
Dividendos de 'ABBVIE INC'
Fecha ex-dividendo | Dividendo por acción |
---|---|
15.04.2025 | 1,64 USD |
15.01.2025 | 1,64 USD |
15.10.2024 | 1,55 USD |
15.07.2024 | 1,55 USD |
12.04.2024 | 1,55 USD |
12.01.2024 | 1,55 USD |
12.10.2023 | 1,48 USD |
13.07.2023 | 1,48 USD |
13.04.2023 | 1,48 USD |
12.01.2023 | 1,48 USD |
Símbolos de cotización
Nombre | Símbolo |
---|---|
Frankfurt | 4AB.F |
NYSE | ABBV |
XETRA | 4AB.DE |
Otras acciones
Los inversores que tienen ABBVIE INC también tienen las siguientes acciones en su cartera:
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras.
Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.